Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
- PMID: 17293360
- DOI: 10.1093/brain/awl370
Autologous haematopoietic stem cell transplantation fails to stop demyelination and neurodegeneration in multiple sclerosis
Abstract
The present study analyses autopsy material from five multiple sclerosis patients who received autologous stem cell transplantation. A total of 53 white matter lesions were investigated using routine and immunohistochemical stainings to characterize the demyelinating activity, inflammatory infiltrates, acutely damaged axons and macrophages/microglial cells. We found evidence for ongoing active demyelination in all of the five patients. The inflammatory infiltrate within the lesions showed only very few T cells and CD8+ cytotoxic T cells dominated the T cell population. B cells and plasma cells were completely absent from the lesions. High numbers of acutely damaged axons were found in active lesion areas. Tissue injury was associated with activated macrophages/microglial cells. The present results indicate that ongoing demyelination and axonal degeneration exist despite pronounced immunosuppression. Our data parallel results from some of the clinical phase I/II studies showing continued clinical disease progression in multiple sclerosis patients with high expanded disability system scores despite autologous stem cell transplantation.
Comment in
-
Is haematopoietic stem cell transplantation a treatment option for severe MS or not?Brain. 2007 May;130(Pt 5):1181-2. doi: 10.1093/brain/awm088. Brain. 2007. PMID: 17472982 No abstract available.
-
Autologous HSCT for advanced MS: is the glass half-empty or really half-full?Brain. 2008 Feb;131(Pt 2):e89; author reply e90. doi: 10.1093/brain/awm180. Epub 2007 Sep 30. Brain. 2008. PMID: 17908695 No abstract available.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials
